Author:
Sosa Alan J.,Thames Howard D.,Sanders Jeremiah W.,Choi Seungtaek L.,Nguyen Quynh-Nhu,Mok Henry,Ron Zhu X.,Shah Shalin,Mayo Lauren L.,Hoffman Karen E.,Tang Chad,Lee Andrew K.,Pugh Thomas J.,Kudchadker Reena,Frank Steven J.
Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology
Reference34 articles.
1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022
2. Trends in treatments for prostate cancer in the United States, 2010–2015;Wang;Am J Cancer Res,2021
3. Trends in diagnosis and disparities in initial management of high-risk prostate cancer in the US;Agrawal;JAMA Netw Open,2020
4. Dose escalation for prostate adenocarcinoma: A long-term update on the outcomes of a phase 3, single institution randomized clinical trial;Pasalic;Int J Radiat Oncol Biol Phys,2019
5. Long-term results of the Dutch randomized prostate cancer trial: impact of dose-escalation on local, biochemical, clinical failure, and survival;Heemsbergen;Radiother Oncol,2014
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献